Carving out new benchmark for glyphosate transparency:
Bayer provides access to its glyphosate safety study reports
Monheim, March 28, 2019 – As of today, all 107 Bayer-owned glyphosate safety study reports that were submitted to the European Food Safety Authority (EFSA) as part of the substance authorization process in the European Union (EU) are accessible on the Bayer dedicated transparency platform. In doing so, the company delivers on its commitment to more transparency, including continued transparency with its crop protection safety studies following the acquisition of Monsanto.
“Transparency is a catalyst for trust, so more transparency is a good thing for consumers, policy-makers and businesses. As an innovation company, safety is our top priority and we are completely committed to doing everything we can to ensure that our products are safe for people and the environment,” said Liam Condon, member of the Board of Management of Bayer AG and president of the Crop Science Division. “By making our detailed scientific safety data publically available, we encourage everybody interested to see for themselves how comprehensive our approach to safety is. We embrace the opportunity to engage in dialogue and hope this will contribute to more trust in sound science.”
This new addition to the Bayer Transparency website follows last December’s publication of more than 300 glyphosate safety study summaries submitted under the EU substance authorization process for plant protection products. Access has now been enabled to all the related in-depth glyphosate safety studies to which Bayer wholly owns the rights. Due to legal restrictions, Bayer cannot release the glyphosate studies conducted and owned by third parties. For more information, please visit our FAQ page.
About the Bayer Transparency Initiative
Bayer has made a voluntary commitment for transparency in 2017 by setting a new standard with its Bayer Transparency Platform. The company has made its safety data, which was previously only shared with regulators, available to the general public in order to connect with the scientific community, build trust and foster an open, science-based dialogue about plant protection products. To date, Bayer has made information on 28 active ingredients available on its transparency website with more to come.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.com.